TDOC vs. RDNT, BTSG, SHC, SGRY, CON, PRVA, LFST, VCYT, ADUS, and WGS
Should you be buying Teladoc Health stock or one of its competitors? The main competitors of Teladoc Health include RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), LifeStance Health Group (LFST), Veracyte (VCYT), Addus HomeCare (ADUS), and GeneDx (WGS). These companies are all part of the "healthcare" industry.
Teladoc Health vs.
RadNet (NASDAQ:RDNT) and Teladoc Health (NYSE:TDOC) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, community ranking, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.
Teladoc Health received 329 more outperform votes than RadNet when rated by MarketBeat users. However, 66.05% of users gave RadNet an outperform vote while only 62.50% of users gave Teladoc Health an outperform vote.
RadNet currently has a consensus price target of $69.75, suggesting a potential upside of 17.64%. Teladoc Health has a consensus price target of $9.60, suggesting a potential upside of 29.78%. Given Teladoc Health's higher probable upside, analysts clearly believe Teladoc Health is more favorable than RadNet.
RadNet has a net margin of -0.25% compared to Teladoc Health's net margin of -37.91%. RadNet's return on equity of 4.29% beat Teladoc Health's return on equity.
In the previous week, Teladoc Health had 1 more articles in the media than RadNet. MarketBeat recorded 9 mentions for Teladoc Health and 8 mentions for RadNet. Teladoc Health's average media sentiment score of 1.35 beat RadNet's score of 0.97 indicating that Teladoc Health is being referred to more favorably in the news media.
RadNet has higher earnings, but lower revenue than Teladoc Health. RadNet is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.
RadNet has a beta of 1.43, indicating that its share price is 43% more volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500.
77.9% of RadNet shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 5.6% of RadNet shares are owned by company insiders. Comparatively, 0.6% of Teladoc Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
RadNet beats Teladoc Health on 11 of the 19 factors compared between the two stocks.
Get Teladoc Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Teladoc Health Competitors List
Related Companies and Tools
This page (NYSE:TDOC) was last updated on 6/11/2025 by MarketBeat.com Staff